58.30MMarket Cap-303P/E (TTM)
3.550High3.400Low61.62KVolume3.510Open3.580Pre Close215.29KTurnover0.40%Turnover RatioLossP/E (Static)16.92MShares57.20052wk High0.25P/B52.59MFloat Cap3.23052wk Low--Dividend TTM15.26MShs Float57.200Historical High--Div YieldTTM4.19%Amplitude3.230Historical Low3.493Avg Price1Lot Size
Mural Oncology Stock Forum
NEWS
Mural Oncology Presents Clinical Data from ARTISTRY-3 at the American Society of Clinical Oncology Annual Meeting
Mural Oncology presented data from its ARTISTRY-3 trial at the ASCO annual meeting, showing that less frequent dosing of nemvaleukin alfa (nemvaleukin), an engineered IL-2 cytokine, is well-tolerated and effective.
The trial shifted from five daily infusions to two infusions per three-week cycle, both as a single agent and in combination with pembrolizu...
NEWS
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
👃
👄
$Mural Oncology(MURA.US)$
No comment yet